Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

Clinical trial NCT00964028 · COMPLETED

Trial details

NCT number: NCT00964028
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Acellular Pertussis Diphtheria Tetanus Poliomyelitis

Start date: 2009-12-01
Primary completion: 2010-04-12
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.